COMMUNIQUÉS West-GlobeNewswire

Vistin Pharma ASA : 11 per cent revenue growth in third quarter 2018
25/10/2018
Oslo, Norway, 25 October 2018 Vistin Pharma delivered a revenue growth of 11 percent from NOK 46.7 million in the third quarter 2017 to NOK 51.7 million in the third quarter 2018. The underlying demand for metformin is [...]
argenx reports third quarter 2018 financial results and provides business update
25/10/2018
October 25, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
25/10/2018
Regulated information Gosselies, Belgium, 25 October 2018, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
25/10/2018
Information réglementée Gosselies, Belgique, le 25 octobre 2018, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]
MyoKardia Announces Initiative to Create Hypertrophic Cardiomyopathy Patient Community in Collaboration with 23andMe
25/10/2018
First-of-its-kind Digital Platform for HCM Patients Intended to Provide a Powerful Patient Resource to Improve Disease Understanding and Deepen Patient Engagement and Advocacy SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 [...]
Oncolytics Biotech® Establishes New At-The-Market Facility
25/10/2018
CALGARY, Alberta and SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus that turns cold [...]
LeMaitre Vascular Acquires Cardial Business of BD
24/10/2018
BURLINGTON, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the assets of Cardial, a subsidiary of BD (Becton, Dickinson & Company), located in [...]
Supernus to Host Third Quarter 2018 Earnings Conference Call
24/10/2018
ROCKVILLE, Md., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
MyoKardia Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy
24/10/2018
Key Remaining Study in Registration Program for oHCM Enables Assessment of Mavacamten’s Potential for Disease Modification SOUTH SAN FRANCISCO, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a [...]
Align Technology Announces Third Quarter 2018 Financial Results
24/10/2018
Q3 revenues up 31.2% year-over-year to a record $505.3 million, and diluted EPS of $1.24 Q3 operating income up 26.8% year-over-year to $125.2 million, operating margin of 24.8% Q3 total Invisalign case shipments up 35. [...]
Sarepta Therapeutics Announces Third Quarter 2018 Financial Results and Recent Corporate Developments
24/10/2018
-- Third quarter 2018 EXONDYS 51® (eteplirsen) total net revenues of $78.5 million -- CAMBRIDGE, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine [...]
Intercept to Announce Third Quarter 2018 Financial Results on October 31, 2018
24/10/2018
NEW YORK, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
OrthoPediatrics Corp. to Report Third Quarter 2018 Financial Results on October 31, 2018
24/10/2018
Conference Call to Discuss Results on November 1, 2018 at 8:00 a.m. ET WARSAW, Ind., Oct. 24, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively [...]
MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe
24/10/2018
Clearance Resolves Outstanding FDA Advisory Notice Issues IRVINE, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Monteris Medical on the FDA Clearance of its new NeuroBlate Optic [...]
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
24/10/2018
First nine months financial results: Group revenues increased by €98.7 million to €205.1 million Operating loss decreased by €9.1 million to €53.5 million Net loss decreased by €41.7 million to €44.2 million Cash and [...]
Galapagos and AbbVie restructure CF collaboration
24/10/2018
Mechelen, Belgium, Chicago, US; 24 October 2018; 22.02 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) and AbbVie, Inc (NYSE: ABBV) announce a restructuring of their cystic fibrosis (CF) alliance [...]
Topline interim results of FALCON trial Part 1 in CF
24/10/2018
Mechelen, Belgium; 24 October 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces topline interim results of Part 1 of the FALCON trial in cystic fibrosis (CF). The FALCON trial [...]
Genesis HealthCare Expects to Release Third Quarter 2018 Results on November 7, 2018
24/10/2018
KENNETT SQUARE, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2018
24/10/2018
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]

Pages